Skip to Content

The threat of litigation looms as Purdue Pharma returns to settlement talks

Associated Press

OxyContin maker Purdue Pharma, the family that owns it and lawyers for thousands of parties with claims against it are getting ready to work on a new settlement after the U.S. Supreme Court rejected the last one. The previous deal was fueled by up to $6 billion from members of the Sackler family. The high court ruled that family members who did not seek bankruptcy protection could not be granted protection from lawsuits over opioids. Lawyers want two months to work out a deal. One group is seeking permission to sue the Sacklers over money they transferred from Purdue.

Article Topic Follows: AP National

Jump to comments ↓

Author Profile Photo

Associated Press

BE PART OF THE CONVERSATION

KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content